ArticleInternational journal of clinical and experimental pathology2019

Dihydrofolate reductase as a predictor for poor response to platinum-based chemotherapy in epithelial ovarian cancer.

Min Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.